GAIN THERAPEUTICS, INC (GANX) Operating cash flow 2020–2025
GAIN THERAPEUTICS, INC (GANX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.5MFY2025 · since FY2020: -$3.2M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.5M | +2.2% |
| FY2024 | -$18.9M | -0.0% |
| FY2023 | -$18.9M | -28.4% |
| FY2022 | -$14.7M | -18.8% |
| FY2021 | -$12.4M | -281.6% |
| FY2020 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GANX financial trends
GANX RevenueGANX Net incomeGANX Net marginGANX Gross profitGANX Gross marginGANX Operating incomeGANX Operating marginGANX Free cash flowGANX Capital expendituresGANX Return on equityGANX Stock buybacksGANX Dividends paidGANX Total assetsGANX Total liabilitiesGANX Shareholders’ equityGANX overview →